» Articles » PMID: 3252031

Morphine Effects on Locus Ceruleus Neurons Are Dependent on the State of Arousal and Availability of External Stimuli: Studies in Anesthetized and Unanesthetized Rats

Overview
Specialty Pharmacology
Date 1988 Mar 1
PMID 3252031
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Because the physiological characteristics of noradrenergic locus ceruleus (LC) neurons differ in anesthetized and unanesthetized rats, the effects of morphine on LC activity recorded in both conditions were compared. Intracerebroventricular administration of morphine inhibited spontaneous LC discharge of both anesthetized and unanesthetized rats but morphine was at least 10 times more potent in anesthetized rats. In anesthetized rats LC discharge evoked by sciatic nerve stimulation was insensitive to doses of morphine (0.03 or 0.1 microgram) that inhibited LC spontaneous activity. Only the highest dose of morphine (0.3 microgram) which inhibited completely tonic activity decreased significantly evoked discharge. In parallel experiments in unanesthetized rats, the presentation of auditory stimuli evoked a pattern of LC discharge similar to that evoked by sciatic nerve stimulation in anesthetized rats. Morphine (1.0 and 3.0 micrograms) decreased both spontaneous and evoked activity in these rats; however, spontaneous LC discharge was more sensitive to morphine, as was observed with anesthetized rats. Quantitative analyses of these effects indicated that morphine tends to alter the pattern of LC discharge to sensory stimuli such that the signal-to-noise ratio (ratio of evoked/tonic activity during stimulus presentation) is increased. Morphine effects were reversed by naltrexone (1.0 mg/kg s.c.) in anesthetized rats and 1.0 microgram i.c.v. in unanesthetized rats. The present results indicate that the degree of arousal and the availability of environmental stimuli are important determinants of opiate effects on LC activity.

Citing Articles

A historical perspective on clonidine as an alpha-2A receptor agonist in the treatment of addictive behaviors: Focus on opioid dependence.

Gold M, Blum K, Bowirrat A, Pinhasov A, Bagchi D, Dennen C INNOSC Theranostics Pharmacol Sci. 2024; 7(3).

PMID: 39119149 PMC: 11308626. DOI: 10.36922/itps.1918.


Noradrenergic circuits and signaling in substance use disorders.

Downs A, McElligott Z Neuropharmacology. 2022; 208:108997.

PMID: 35176286 PMC: 9498225. DOI: 10.1016/j.neuropharm.2022.108997.


Locus coeruleus: a new look at the blue spot.

Poe G, Foote S, Eschenko O, Johansen J, Bouret S, Aston-Jones G Nat Rev Neurosci. 2020; 21(11):644-659.

PMID: 32943779 PMC: 8991985. DOI: 10.1038/s41583-020-0360-9.


The role of catecholamines in modulating responses to stress: Sex-specific patterns, implications, and therapeutic potential for post-traumatic stress disorder and opiate withdrawal.

Ross J, Van Bockstaele E Eur J Neurosci. 2020; 52(1):2429-2465.

PMID: 32125035 PMC: 8351794. DOI: 10.1111/ejn.14714.


Amyloid beta peptides, locus coeruleus-norepinephrine system and dense core vesicles.

Ross J, Reyes B, Van Bockstaele E Brain Res. 2018; 1702:46-53.

PMID: 29577889 PMC: 6375485. DOI: 10.1016/j.brainres.2018.03.009.